Brief Communications
d-Aspartate Regulates Melanocortin Formation and Function: Behavioral Alterations in d-Aspartate Oxidase-Deficient Mice
Alex S. Huang, Anne Beigneux, Zachary M. Weil, Paul M. Kim, Mark E. Molliver, Seth Blackshaw, Randy J. Nelson, Stephen G. Young and Solomon H. Snyder
Journal of Neuroscience 8 March 2006, 26 (10) 2814-2819; https://doi.org/10.1523/JNEUROSCI.5060-05.2006
Alex S. Huang
Departments of 1Neuroscience, 2Pharmacology, and 3Psychiatry and Behavioral Sciences, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, 4Department of Medicine, Division of Cardiology, David Geffen School of Medicine, University of California, Los Angeles, California 90095, and 5Departments of Psychology and Neuroscience, Institute for Behavioral Medicine Research, The Ohio State University, Columbus, Ohio 43210
Anne Beigneux
Departments of 1Neuroscience, 2Pharmacology, and 3Psychiatry and Behavioral Sciences, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, 4Department of Medicine, Division of Cardiology, David Geffen School of Medicine, University of California, Los Angeles, California 90095, and 5Departments of Psychology and Neuroscience, Institute for Behavioral Medicine Research, The Ohio State University, Columbus, Ohio 43210
Zachary M. Weil
Departments of 1Neuroscience, 2Pharmacology, and 3Psychiatry and Behavioral Sciences, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, 4Department of Medicine, Division of Cardiology, David Geffen School of Medicine, University of California, Los Angeles, California 90095, and 5Departments of Psychology and Neuroscience, Institute for Behavioral Medicine Research, The Ohio State University, Columbus, Ohio 43210
Paul M. Kim
Departments of 1Neuroscience, 2Pharmacology, and 3Psychiatry and Behavioral Sciences, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, 4Department of Medicine, Division of Cardiology, David Geffen School of Medicine, University of California, Los Angeles, California 90095, and 5Departments of Psychology and Neuroscience, Institute for Behavioral Medicine Research, The Ohio State University, Columbus, Ohio 43210
Mark E. Molliver
Departments of 1Neuroscience, 2Pharmacology, and 3Psychiatry and Behavioral Sciences, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, 4Department of Medicine, Division of Cardiology, David Geffen School of Medicine, University of California, Los Angeles, California 90095, and 5Departments of Psychology and Neuroscience, Institute for Behavioral Medicine Research, The Ohio State University, Columbus, Ohio 43210
Seth Blackshaw
Departments of 1Neuroscience, 2Pharmacology, and 3Psychiatry and Behavioral Sciences, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, 4Department of Medicine, Division of Cardiology, David Geffen School of Medicine, University of California, Los Angeles, California 90095, and 5Departments of Psychology and Neuroscience, Institute for Behavioral Medicine Research, The Ohio State University, Columbus, Ohio 43210
Randy J. Nelson
Departments of 1Neuroscience, 2Pharmacology, and 3Psychiatry and Behavioral Sciences, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, 4Department of Medicine, Division of Cardiology, David Geffen School of Medicine, University of California, Los Angeles, California 90095, and 5Departments of Psychology and Neuroscience, Institute for Behavioral Medicine Research, The Ohio State University, Columbus, Ohio 43210
Stephen G. Young
Departments of 1Neuroscience, 2Pharmacology, and 3Psychiatry and Behavioral Sciences, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, 4Department of Medicine, Division of Cardiology, David Geffen School of Medicine, University of California, Los Angeles, California 90095, and 5Departments of Psychology and Neuroscience, Institute for Behavioral Medicine Research, The Ohio State University, Columbus, Ohio 43210
Solomon H. Snyder
Departments of 1Neuroscience, 2Pharmacology, and 3Psychiatry and Behavioral Sciences, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, 4Department of Medicine, Division of Cardiology, David Geffen School of Medicine, University of California, Los Angeles, California 90095, and 5Departments of Psychology and Neuroscience, Institute for Behavioral Medicine Research, The Ohio State University, Columbus, Ohio 43210
Published eLetters
Guidelines
As a forum for professional feedback, submissions of letters are open to all. You do not need to be a subscriber. To avoid redundancy, we urge you to read other people's letters before submitting your own. Name, current appointment, place of work, and email address are required to send a letter, and will be published with your review. We also require that you declare any competing financial interests. Unprofessional submissions will not be considered or responded to.
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Journal of Neuroscience
Vol. 26, Issue 10
March 8, 2006
d-Aspartate Regulates Melanocortin Formation and Function: Behavioral Alterations in d-Aspartate Oxidase-Deficient Mice
Alex S. Huang, Anne Beigneux, Zachary M. Weil, Paul M. Kim, Mark E. Molliver, Seth Blackshaw, Randy J. Nelson, Stephen G. Young, Solomon H. Snyder
Journal of Neuroscience 8 March 2006, 26 (10) 2814-2819; DOI: 10.1523/JNEUROSCI.5060-05.2006
d-Aspartate Regulates Melanocortin Formation and Function: Behavioral Alterations in d-Aspartate Oxidase-Deficient Mice
Alex S. Huang, Anne Beigneux, Zachary M. Weil, Paul M. Kim, Mark E. Molliver, Seth Blackshaw, Randy J. Nelson, Stephen G. Young, Solomon H. Snyder
Journal of Neuroscience 8 March 2006, 26 (10) 2814-2819; DOI: 10.1523/JNEUROSCI.5060-05.2006
Jump to section
Responses to this article
Jump to comment:
No eLetters have been published for this article.